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Carbofuran (2,3-dihydro-2,2-dimethylbenzo-
furan-7-yl methylcarbamate) is a carbamate
insecticide registered for use on a variety of
food crops including corn, alfalfa, rice, and
tobacco (Tobin 1970). An estimated 5 million
pounds of carbofuran are used annually in the
United States, 48% of which is used on corn
crops (Thelin and Gianessi 2000). In addition
to agriculturally related exposure, the general
U.S. population may also be commonly
exposed to carbofuran. Forty-five percent of
urban African-American women and their
newborns had detectable levels of carbofuran
in maternal plasma and umbilical cord blood
(Whyatt et al. 2003).
Carbofuran has been demonstrated to have
weak mutagenic activity in some, but not all,
strains of Salmonella typhimurium (Hour et al.
1998; Moriya et al. 1983). Carbofuran induces
chromosomal aberrations and micronucleus
formation in exposed mice (Chauhan et al.
2000) and N-nitrosocarbofuran, derived from
the nitrosation of carbofuran, has demonstrated
mutagenic properties (Yoon et al. 2001). The
evidence from animal models is inconclusive.
Two studies demonstrated that carbofuran
was able to induce lymphoma in Swiss mice
(Borzsonyi and Pinter 1977; Borzsonyi et al.
1976), but carcinogenicity of carbofuran was
not evident in several 2-year dietary studies
conducted on rats (Gupta 1994).
In addition to the potential carcinogenicity
of N-nitrosocarbofuran, carbamate pesticides
have been shown to impair immunity in mice
(Barnett et al. 1980; Street and Sharma 1975)
and in humans (Fiore et al. 1986). Several epi-
demiologic investigations have examined
exposure to carbamate pesticides, including
carbofuran, and the risk of cancer. McDufﬁe
et al. (2001) found elevated risk for non-
Hodgkin lymphoma (NHL) associated with
the use of carbamate pesticides [odds ratio
(OR) = 1.9; 95% confidence interval (CI),
1.2–3.0], but not with carbofuran speciﬁcally
(OR = 1.6; 95% CI, 0.7–3.9). Zheng et al.
(2001) observed elevated risk among farmers
who used carbofuran (OR = 1.6; 95% CI,
1.1–2.3). In a nested case–control study of
structural pest control workers in Florida,
Pesatori et al. (1994) reported an increase in
the OR for lung cancer among those who used
carbamate insecticides (OR = 16.3; 95% CI,
2.2–122.5). Increased risk of lung cancer was
not evident, however, in a population-based
case–control study among residents of
Saskatchewan, Canada (McDufﬁe et al. 1990).
Considering the limited epidemiologic data on
carbofuran and cancer, we examined the rela-
tionship between occupational exposure to
carbofuran and several tumor sites in the
Agricultural Health Study.
Materials and Methods
A detailed description the Agricultural Health
Study (AHS) has been previously published
(Alavanja et al. 1996). Briefly, the AHS is a
prospective cohort study of 57,311 licensed
restricted-use pesticide applicators and 32,347
of their spouses in Iowa and North Carolina.
Licensed pesticide applicators include private
applicators who are farmers and commercial
applicators who are employed by pest control
companies or businesses that use pesticides
such as warehouse operators and grain millers.
Recruitment started in December 1993 and
ended 4 years later in December 1997. The
National Death Index and state death registries
were used to ascertain the vital status of cohort
members. Incident cancers diagnosed between
December 1993 and 31 December 2001 were
identiﬁed through tumor registries and coded
using the International Classiﬁcation of Diseases
for Oncology (ICD-O-2) (Percy et al. 1990).
The average follow-up time was 6.4 years.
Participants (n = 946) who moved out of
either Iowa or North Carolina were censored
in the year they moved. All participants
provided informed consent; the protocol was
approved by all appropriate Institutional
Review Boards.
Exposure assessment. Study participants
were asked to complete a self-administered
questionnaire at the time of enrollment.
We obtained information on 50 pesticides.
Detailed data about years of use, frequency of
use in an average year, and when use began
were collected for 22 pesticides including car-
bofuran, and information on ever/never use of
28 other pesticides was collected at the time of
enrollment. In addition, information regard-
ing application methods and the use of per-
sonal protective equipment was collected.
Participants also supplied information about
important potential confounders such as
smoking habits, alcohol intake, fruit and veg-
etable consumption, other agricultural activi-
ties, and non-farm–related occupational
exposures. A previous analysis of the reliability
of the AHS questionnaire showed that the
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Carbofuran is a carbamate insecticide registered for use on a variety of food crops including corn,
alfalfa, rice, and tobacco. An estimated 5 million pounds of carbofuran is used annually in the
United States, and 45% of urban African-American women have detectable levels of carbofuran in
their plasma. Nitrosated carbofuran has demonstrated mutagenic properties. We examined expo-
sure to carbofuran and several tumor sites among 49,877 licensed pesticide applicators from Iowa
and North Carolina enrolled in the Agricultural Health Study. We obtained information regard-
ing years of use, frequency of use in an average year, and when use began for 22 pesticides using
self-administered questionnaires. Poisson regression was used to calculate rate ratios (RR) and
95% conﬁdence intervals (CIs) adjusting for potential confounders. Lung cancer risk was 3-fold
higher for those with > 109 days of lifetime exposure to carbofuran (RR = 3.05; 95% CI,
0.94–9.87) compared with those with < 9 lifetime exposure days, with a signiﬁcant dose–response
trend for both days of use per year and total years of use. However, carbofuran use was not associ-
ated with lung cancer risk when nonexposed persons were used as the referent. In addition, carbo-
furan exposure was not associated with any other cancer site examined. Although carbamate
pesticides are suspected human carcinogens, these results should be interpreted cautiously because
there was no a priori hypothesis speciﬁcally linking carbofuran to lung cancer. Key words: agricul-
ture, cancer incidence, carbofuran, lung cancer, pesticides. Environ Health Perspect 113:285–289
(2005). doi:10.1289/ehp.7451 available via http://dx.doi.org/ [Online 2 December 2004]level of agreement for pesticide use was similar
to other factors routinely estimated with epi-
demiologic questionnaires (Blair et al. 2002).
For these analyses, we estimated exposure
with total lifetime exposure-days to carbofuran.
Lifetime exposure-days was defined as the
product of the number of years a participant
personally mixed or applied carbofuran and the
number of days in an average year that carbo-
furan was used. In addition, we incorporated
an algorithm developed by Dosemeci et al.
(2002) to estimate an exposure intensity score
and applied it to lifetime exposure-days metric.
Briefly, the intensity score was designed to
incorporate aspects of pesticide use that can
modify actual exposure, including whether an
applicator personally mixed or prepared the
pesticides for application, what type of applica-
tion methods were used, the repair of pesticide
application equipment, and the use of personal
protective equipment during these activities.
Dermal absorption is generally considered the
major route of exposure for pesticide appli-
cators (Maroni et al. 2000; Tobin 1970).
Therefore, the intensity score heavily weighted
the use of protective gloves and to a lesser
extent protective clothing. We calculated
intensity-weighted exposure-days as the prod-
uct of the intensity score and total lifetime
exposure-days. In addition to these exposure
metrics, we also assessed the frequency (i.e.,
number of days/year applied) and the duration
(total number of years applied) of carbofuran
exposure in relation to cancer risk.
Statistical analysis. Prevalent cancer cases
(n = 1,074) and applicators who failed to pro-
vide information about carbofuran use (n =
6,360) were excluded, leaving 49,877 cohort
members from this analysis. Most of the sub-
jects who were missing information on carbo-
furan use and other potential confounders were
from North Carolina (64%). Two reference
groups were used for these analyses: pesticide
applicators who reported never using carbofu-
ran and pesticide applicators whose use of car-
bofuran was in the lowest tertile of exposure.
We used Poisson regression to calculate
rate ratios (RR) and 95% CIs. Lifetime expo-
sure-days and intensity-weighted lifetime expo-
sure-days to carbofuran were categorized into
tertiles based on the distribution in all the can-
cer cases. The highest tertile was then divided
at its midpoint to increase the resolution at
higher exposure levels. We limited analyses to
tumor sites where there were more than five
cases in each category of exposure. Models
were adjusted for age at enrollment (< 40,
40–49, 50–59, ≥ 60 years), sex, education
(≤ high school graduate, > high school gradu-
ate), smoking (by pack-years: never, ≤ 14,
> 14), alcohol consumption during the last
12 months (yes/no), family history of cancer
(yes/no), year at enrollment, state of residence
(Iowa/North Carolina), and the ﬁve pesticides
most highly correlated with carbofuran use
[permethrin (crop), S-ethyl dipropylthiocar-
bamate (EPTC), chlorpyrifos, fonofos, and
trichlorfon: never, low, high exposure]. The
correlation coefﬁcients for these ﬁve pesticides
ranged between 0.69 (permethrin) and 0.85
(trichlorfon). The cut point that dichotomized
low and high exposure for each pesticide cor-
related with carbofuran was determined by the
median for lifetime exposure-days for that par-
ticular pesticide. We based the cut points for
days of use per year and years of use on the
categorical responses to the following ques-
tions: “In an average year when you personally
used this pesticide, how many days did you
use it?” (< 5 days; 5–9 days; 10–19 days;
20–39 days; 40–59 days; 60–150 days; or
> 150 days) and “How many years did you per-
sonally mix or apply this pesticide?” (≤ 1 year
or less; 2–5 years; 6–10 years; 11–20 years;
21–30 years; or > 30 years). For the analysis,
we collapsed the upper categories to ensure
that there were approximately five or more
cases in each category.
We determined the most parsimonious
model (reduced) with –2 log-likelihood ratio
tests by removing each covariate from the satu-
rated (full) model and retaining only those
variables that resulted in signiﬁcant –2 log-like-
lihood ratio (Hosmer and Lemeshow 1989).
The most parsimonious model included age,
smoking (never, < 14 pack-years, and ≥ 14
pack-years of smoking), family history of can-
cer, and trichlorofon and permethrin exposure.
To further control for potential con-
founding by smoking, we also adjusted for
several other smoking variables including
smoking status (never, former, current), pack-
years of smoking, duration of smoking, and
number of cigarettes smoked per day. The
inclusion of these additional smoking vari-
ables did not appreciably alter the risk esti-
mates and were not retained in the models.
Linear trends were assessed using the p-value
of the coefﬁcient of the exposure treated as a
continuous value using the median value for
each tertile of exposure in the models also
adjusting for covariates (Breslow and Day
1987). Tests for interaction were performed
by determining the signiﬁcance of the coefﬁ-
cient of the product term of the exposure and
the purported effect modiﬁer.
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Table 1. Selected characteristics of applicators, by carbofuran exposure [no. (%)] in the AHS (1993–1997).
Characteristic Nonexposed Low exposed High exposed
Age (years)
< 40 14,023 (37.6) 1,032 (21.8) 1,739 (22.1)
40–49 10,217 (27.4) 1,470 (31.0) 2,532 (32.1)
50–59 6,802 (18.3) 1,216 (25.7) 2,056 (26.1)
≥ 60 6,210 (16.7) 1,016 (21.5) 1,557 (19.7)
Sex
Male 36,069 (96.8) 4,698 (99.2) 7,819 (99.2)
Female 1,190 (3.2) 36 (0.8) 65 (0.8)
State
Iowa 25,459 (68.3) 3,421 (72.3) 4,908 (62.3)
North Carolina 11,800 (31.7) 1,313 (27.7) 2,976 (37.7)
Applicator type
Farmer 33,341 (89.5) 4,574 (96.6) 7,355 (93.3)
Commercial 3,918 (10.5) 160 (3.4) 529 (6.7)
Smoking
Never 19,976 (54.0) 2,509 (53.2) 4,056 (51.6)
Former 10,587 (28.7) 1,577 (33.4) 2,560 (32.6)
Current 6,396 (17.3) 635 (13.5) 1,241 (15.8)
Alcohol usea
Yes 25,352 (69.0) 3,260 (69.1) 5,290 (67.8)
Education
≤ High school 21,270 (57.2) 2,503 (53.0) 4,372 (55.5)
> High school 15,897 (42.8) 2,219 (47.0) 3,504 (44.5)
Family history of cancer
Yes 13,339 (38.0) 2,099 (46.5) 3,404 (45.9)
Corn production
Yes 24,967 (67.0) 3,801 (80.0) 6,226 (79.0)
Other pesticide use
Trichlorofon 305 (0.8) 37 (0.8) 160 (2.1)
Fonofos 5,410 (14.5) 1,591 (34.4) 2,969 (38.6)
Chlorpyrifos 12,908 (34.7) 2,534 (53.8) 4,982 (63.5)
EPTC 6,112 (16.8) 1,351 (29.5) 2,417 (31.8)
Permethrinb 4,078 (11.1) 913 (19.9) 2,060 (27.1)
Person-years 240549.2 29867.9 50852.2
No. of other pesticides usedc 11.5 ± 6.6 18.3 ± 6.6 20.4 ± 7.2
Follow-up (years)c 6.5 ± 1.4 6.3 ± 1.4 6.5 ± 1.4
Smoking (pack-years)c
Former smokers 15.4 ± 20.1 15.0 ± 18.9 15.8 ± 20.2
Current smokers 22.0 ± 19.9 24.9 ± 21.3 27.0 ± 22.2
aReported alcohol consumption within the last 12 months. bPermethrin for use on crops. cMean ± SD.Results
Twenty-ﬁve percent of the pesticide applicators
reported ever using carbofuran. Demographic
characteristics of the non-carbofuran exposed
and carbofuran exposed [categorized as low
(tertile 1) and high exposure (tertiles 2 and 3)]
are depicted in Table 1. The non-carbofuran
exposed tended to be younger than either
the low- or high-exposed carbofuran cohorts.
The nonexposed were also more likely to be
female than the exposed, although there were
few women applicators in the study overall.
Smoking status (never, former, or current), alco-
hol consumption in the last 12 months, attained
education, state of residence, years of follow-up,
and family history of cancer were all similar
between the three groups. The mean number of
smoking pack-years; however, sequentially
increased between nonexposed, low-exposed,
and the high-exposed groups. Cohort members
exposed to carbofuran were more likely than
nonexposed cohort members to be involved in
corn production. Additionally, those exposed to
carbofuran used more types of pesticides than
non-carbofuran–exposed subjects.
We report on all cancer sites combined and
tumor sites where sufﬁcient numbers (at least
five cases per cell) of cases occurred during
follow-up to warrant statistical analyses: all
lymphatic–hematopoietic cancers (Hodgkin,
non-Hodgkin, multiple myeloma, and
leukemia), NHL, and colon, lung, and prostate
cancers.
Carbofuran exposure was not associated
with the incidence of all cancers combined
(Table 2) or with any tumor site examined
except lung cancer. Lung cancer risk appeared
to be positively associated with exposure to car-
bofuran when the low exposed were used as the
reference group, although a test of the linear
trend was not signiﬁcant (p for trend = 0.07).
The lung cancer rate ratio was increased 3-fold
among those with more than 109 lifetime-days
of use (RR = 3.05; 95% CI, 0.94–9.87). When
the nonexposed were used as the reference
group, however, exposure to carbofuran was
not associated with the lung cancer rate ratio.
An exposure–response relationship with
the intensity-weighted lifetime exposure-
days was not clearly evident for lung cancer
(Table 3). Although the upper category of the
intensity-weighted lifetime exposure-days
suggests an increase in the relative risk, the
exposure–response gradient was not mono-
tonic. Regarding the other cancer sites exam-
ined, there was no evidence of an association
with intensity-weighted lifetime exposure-
days when either the nonexposed or the low-
exposed subjects were used as the referent
(data not shown).
The risk of lung cancer also increased
when the frequency of exposure (number of
days of carbofuran use/year) and duration of
exposure (number of years carbofuran was
used) were examined separately (Table 3).
However, the risk was only elevated in appli-
cators who used carbofuran for > 10 years and
for > 10 applications days per year.
To further examine and characterize the
association between carbofuran exposure and
lung cancer, we stratified by smoking status
(never, former, and current), state of resi-
dence (Iowa and North Carolina), histology
(adenocarcinoma and non-adenocarcinoma),
and applicator type (farmer and commercial).
The analyses stratiﬁed by smoking status were
limited in that only one case of lung cancer
was identiﬁed among never smokers and pre-
cluded an analysis restricted to never smokers.
The risk estimates increased as exposure
increased for both former and current smok-
ers (Table 4), and the p for interaction was
not significant (p = 0.36). Carbofuran expo-
sure was associated with nonsignificant
increases in risk in both Iowa (2nd tertile:
RR = 3.79, 95% CI, 0.73–19.55; 3rd tertile:
RR = 5.90, 95% CI, 1.25–27.81) and North
Carolina (2nd tertile: RR = 0.91, 95% CI,
0.20–4.05; 3rd tertile: RR = 2.49, 95% CI,
0.77–8.14). Although the point estimates of
risk were greater in Iowa, the p-value for
the interaction between state and carbofuran
exposure was not signiﬁcant (p for interaction =
0.53). Rate ratios were increased for both ade-
nocarcinoma (2nd tertile: RR = 3.95, 95%
CI, 0.41–38.02; 3rd tertile: RR = 7.87, 95%
CI, 0.94–65.62) and non-adenocarcinoma
(2nd tertile: RR = 1.35, 95% CI, 0.39–4.68;
3rd tertile: RR = 2.90, 95% CI, 1.0–8.36).
Although the risk was considerably higher
for adenocarcinoma, the p for interaction
between histology and carbofuran use was not
signiﬁcant (p = 0.32). There was no evidence
that applicator type either confounded or
modiﬁed the association between carbofuran
and lung cancer risk, although the number
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Table 2. RRs for selected cancers, by lifetime exposure-days to carbofuran among AHS (1993–1997)
applicators with nonexposed and low-exposed groups as referents.
Nonexposed referent Low-exposed referent
Lifetime exposure daysa Cases (n) RR (95% CI) RR (95% CI)
All cancers
0 1,012 1.0
> 0–9 151 0.95 (0.80–1.14) 1.0
10–39 115 0.95 (0.78–1.15) 1.00 (0.78–1.27)
40–109 80 1.05 (0.83–1.33) 1.11 (0.83–1.49)
> 109 51 0.94 (0.70–1.26) 0.96 (0.67–1.37)
Trendb 0.79 0.94
Lymphatic–hematopoietic cancers
0 103 1.0
> 0–9 11 0.68 (0.36–1.30) 1.0
10–39 10 0.82 (0.42–1.60) 1.05 (0.44–2.51)
40–109 11 1.38 (0.72–2.65) 1.56 (0.62–3.92)
> 109 5 0.86 (0.34–2.23) 0.77 (0.23–2.57)
Trendb 0.93 0.74
Non-Hodgkin lymphoma
0 44 1.0
> 0–9 6 0.77 (0.31–1.86) 1.0
10–39 7 1.27 (0.55–2.91) 1.33 (0.44–4.02)
40–109 7 1.40 (0.59–3.30) 1.08 (0.31–3.74)
Trendb 0.40 0.94
Colon
0 80 1.0
> 0–9 10 0.88 (0.45–1.72) 1.0
10–39 9 0.99 (0.49–2.02) 1.03 (0.41–2.56)
40–109 5 0.84 (0.33–2.12) 0.77 (0.25–2.42)
> 109 6 1.34 (0.54–3.31) 1.16 (0.36–3.71)
Trendb 0.68 0.85
Lung
0 98 1.0
> 0–9 6 0.42 (0.18–0.97) 1.0
10–39 8 0.68 (0.33–1.43) 1.61 (0.55–4.69)
40–109 9 1.09 (0.54–2.22) 2.54 (0.85–7.67)
> 109 8 1.38 (0.63–2.99) 3.05 (0.94–9.87)
Trendb 0.46 0.07
Prostate
0 372 1.0
> 0–9 85 1.30 (1.01–1.66) 1.0
10–39 48 0.99 (0.73–1.35) 0.79 (0.55–1.13)
40–109 29 1.03 (0.70–1.53) 0.86 (0.55–1.36)
> 109 17 0.88 (0.53–1.47) 0.73 (0.41–1.31)
Trendb 0.70 0.34
Rate ratios adjusted for age, sex, education, family history of cancer, smoking, alcohol, year of enrollment, state of residence,
and exposure to EPTC, fonofos, trichlorofon, chlorpyrifos, and permethrin.
aYears of use × days of use per year. bp-Value for trend test.of commercial applicator lung cancer cases
was low.
Discussion
An association between carbofuran and lung
cancer has not been previously reported.
Several studies, however, have found pesticides
(Brownson et al. 1993; Wesseling et al. 1999)
and more specifically carbamate pesticides
(Pesatori et al. 1994) to be associated with
lung cancer, although not all studies have
reported this association (McDuffie et al.
1990). In our study, lung cancer was associ-
ated with lifetime exposure-days where risk
increased across exposure categories to more
than a 3-fold increase in the RR in the highest
category when compared with those who had
applied < 9 lifetime exposure-days. The risk
estimates were also elevated when the compo-
nents of the lifetime exposure-days exposure
metric were considered separately. Lung cancer
risk, however, was not associated with carbo-
furan exposure when the intensity-weighted
exposure-days metric was used or when non-
carbofuran–exposed pesticide applicators were
used as the referent.
This inconsistency between the lung can-
cer risk estimates when nonexposed subjects
were used as the referent may be caused partly
by differences between nonexposed and low-
exposed groups with regard to unknown fac-
tors. Initial descriptive analyses indicated that
the nonexposed and the low-exposed groups
had substantial differences with regard to corn
production and the total number of pesticides
used. The observed differences between those
with carbofuran exposure and those without
carbofuran exposure raise the possibility of
confounding due to other unmeasured dif-
ferences between the groups. Given these dif-
ferences, the low-exposed subjects may be a
more appropriate reference group, although
the low-exposed group may be biased as
well. In addition, the inconsistency observed
between the lifetime exposure-days and inten-
sity-weighted lifetime exposure-days metrics
may have occurred because the AHS inten-
sity-weighted algorithm greatly weights der-
mal exposure, and this route may be less
appropriate for sites where the respiratory
tract is the predominant exposure route, such
as the lung. Further, the intensity-weighted
algorithm, as constructed, also reflects more
recent use of personal protective equipment
and application methods. Malignant neo-
plasms generally have a long latency period.
To the extent that recent exposure intensity
does not accurately reﬂect past activities, the
algorithm may increase exposure misclassiﬁca-
tion rather than reduce it.
The association between lung cancer and
carbofuran exposure that we observed when
the low-exposed group was used as the referent
is unlikely to be confounded by smoking
because pack-years of smoking was not corre-
lated with lifetime exposure-days (r = 0.03) or
intensity-weighted lifetime exposure-days (r =
0.02). Furthermore, we adjusted for smoking
(never, < 14 pack-years, and ≥ 14 pack-years)
in the models. Even when we used pack-years
as a continuous variable or a combination of
smoking status (never, former, current), num-
ber of cigarettes smoked per day and number
of years smoked, the risk estimates were simi-
lar with each respective model. We also strati-
fied by smoking status and found that the
association was relatively consistent between
former and current smokers. There were too
few lung cancer cases to determine whether
carbofuran was associated with lung cancer
independent of smoking. Therefore, we can-
not rule out the possibility that the association
between carbofuran and the risk of lung can-
cer is limited to smokers and former smokers.
Agricultural exposure to endotoxin from
rearing livestock has been hypothesized to
reduce the risk of lung cancer (Lange et al.
2003a, 2003b, 2003c; Mastrangelo et al.
1996). Although we did not formally assess
exposure to endotoxin, we conducted an
analysis stratifying the cohort into those who
were engaged in animal husbandry and those
who were not. There was no indication that
animal husbandry modiﬁed the effect of car-
bofuran use on lung cancer risk. In addition,
engaging in animal husbandry did not con-
found the association between carbofuran use
and lung cancer because the RRs were not
altered when we included a binary animal
husbandry variable in the model.
Several previous investigations of NHL have
observed increases in risk associated with carbo-
furan exposure (McDufﬁe et al 2001; Zheng
et al. 2001). In addition, results from several
animal models support the hypothesis that
exposure to carbofuran could be a risk factor for
NHL (Borzsonyi and Pinter 1977; Borzsonyi
et al. 1976). We found little evidence to support
an association between NHL and carbofuran
exposure, although relatively few cases of NHL
had accrued at the time of this analysis.
There is evidence that carcinogenic
N-nitrosocarbofuran is formed from carbo-
furan and nitrites in the stomach. A priori, we
expected carbofuran exposure to be associated
with increased risk for stomach cancer; how-
ever, at the time these analyses were con-
ducted, too few cases of stomach cancer had
occurred in the carbofuran exposed cohorts
for meaningful analysis.
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Table 3. RRs for lung cancer by carbofuran intensity-weighted lifetime exposure days, exposure frequency
(days per year), and exposure duration (years of use) in the AHS (1993–1997).
Full model Reduced model
Cases (n) RR (95% CI)a RR (95% CI)b
Intensity-weighted
lifetime exposure daysc
> 0–63 6 1.0 1.0
64–196 11 2.11 (0.77–5.78) 2.42 (0.89–6.54)
197–487 5 1.19 (0.35–4.03) 1.58 (0.48–5.19)
> 487 9 2.10 (0.69–6.39) 3.40 (1.21–9.58)
Trendd 0.40 0.23
Days of use/year
< 5 9 1.0 1.0
5–9 9 1.53 (0.59–3.95) 1.67 (0.66–4.21)
10–19 9 2.98 (1.07–8.33) 3.84 (1.52–9.71)
≥ 20 4 4.13 (1.13–15.08) 5.63 (1.73–18.35)
Trendd < 0.01 < 0.01
Years of use
≤ 5 16 1.0 1.0
6–10 6 0.80 (0.30–2.10) 1.00 (0.39–2.55)
> 10 9 1.95 (0.80–4.77) 3.00 (1.32–6.81)
Trendd 0.02 < 0.01
aRate ratios adjusted for age, sex, education, family history of cancer, smoking, alcohol, year of enrollment, state of resi-
dence, and exposure to EPTC, fonofos, trichlorofon, chlorpyrifos, and permethrin. bRate ratios adjusted for age, smoking
(never, < 14 pack-years, ≥ 14 pack-years), family history of cancer, and exposure to trichlorofon and permethrin. cYears of
use × days of use per year × intensity score. dp-Value for trend test.
Table 4. RRs for lung cancer and lifetime exposure-days to carbofuran, by smoking status in the AHS
(1993–1997).
Former smokers Current smokers
Lifetime exposure daysa Cases (n) RR (95% CI) Cases (n) RR (95% CI)
> 0–9 3 1.0 3 1.0
10–39 3 1.87 (0.42–8.37) 4 1.75 (0.39–7.90)
> 39 11 4.88 (1.36–17.52) 6 2.49 (0.62–10.00)
Trendb < 0.01 0.23
p for interaction 0.36
Rate ratios adjusted for age, smoking (never, < 14 pack-years, ≥ 14 pack-years), family history of cancer, exposure to
trichlorofon and permethrin.
aYears of use × days of use per year. bp-Value for trend test.Article | Carbofuran exposure and cancer incidence
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There are some important limitations of
this study. Although the incidence of cancers
will increase as the cohort ages, currently we
remain constrained by small numbers of cases
for many tumor sites. For instance, only ﬁve
cases of stomach cancer with exposure to
carbofuran were available for analysis. The
resulting statistical imprecision makes inter-
pretation of risk estimates difficult in some
instances. Another potential concern in pro-
spective studies is loss to follow-up. However,
losses to follow-up (< 2%) were few and
were unlikely to substantially bias the risk
estimates. In addition, pesticides are com-
monly used as formulations where only a per-
centage of the total product applied is the
active ingredient. Given that pesticides are
applied as complex mixtures or solutions, we
cannot rule out the possibility that the combi-
nation or the “inert” ingredients are the actual
carcinogenic compound(s).
The strengths of this study include the
prospective design, where exposure to pesti-
cides was determined before the onset of dis-
ease, thereby eliminating the potential for
recall bias. In addition, the exposure metrics
used in this study represent a major improve-
ment in the classiﬁcation of pesticide exposure
over previous studies, although, undoubtedly,
some exposure misclassification is present in
our estimates as well.
Multicolinearity between pesticides used
may be another potential limitation of this
study. We assessed exposure to 50 pesticides
in registered pesticide applicators who, on
average, used numerous pesticides. Because it
is possible that carbofuran use is related to
several other pesticides, we identiﬁed the ﬁve
most correlated pesticides and adjusted for
them in the model. Overall, exposure to other
individual pesticides was highly correlated
with carbofuran exposure. The correlation
coefficients ranged between 0.69 (perme-
thrin) and 0.85 (trichlorfon). However, these
pesticides did not confound the association
between carbofuran and lung cancer because
the risk estimates were not altered when they
were removed from the model. In addition,
we also adjusted for cumulative lifetime appli-
cation days of all pesticides, which did not
appreciably alter the risk estimates.
Overall, we examined the risk of several
cancer sites in relation to the carbofuran expo-
sure. Carbofuran is a carbamate insecticide
with questionable carcinogenic properties in
animals. The parent compound does not seem
to be genotoxic. However, the metabolites of
carbofuran may be mutagenic, and there is
good evidence that nitrosated carbofuran is
mutagenic. This study suggests that carbofuran
may be associated with an increase in the inci-
dence of lung cancer. Conversely, carbofuran
exposure was not associated with other tumor
sites investigated. The results for lung cancer
are provocative but should be interpreted cau-
tiously in light of the paucity of other studies
to corroborate these ﬁndings, and a reevalua-
tion of carbofuran in the AHS cohort once
more cancer cases have accrued is warranted.
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